Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

35.06
Delayed Data
As of Nov 17
 -0.13 / -0.37%
Today’s Change
34.72
Today|||52-Week Range
44.54
-8.96%
Year-to-Date

Today’s Trading

Previous close35.19
Today’s open35.06
Day’s range34.88 - 35.15
Volume2,585,274
Average volume (3 months)3,977,647
Market cap$86.2B
Dividend yield5.89%
Data as of 4:02pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+14.74%
Earnings growth (next 5 years)+4.05%
Revenue growth (last year)+2.85%
P/E ratio28.0
Price/Sales2.52
Price/Book61.44

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.55-0.89%
NVONovo Nordisk+0.41+0.81%
LLYEli Lilly and Co-0.55-0.66%
CELGCelgene+0.75+0.73%
Data as of 4:03pm ET, 11/17/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts